DOCSLIB.ORG

Fatty Acid Oxidation Is a Dominant Bioenergetic Pathway in Prostate Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fatty Acid Oxidation Is a Dominant Bioenergetic Pathway in Prostate Cancer Prostate Cancer and Prostatic Diseases (2006) 9, 230–234 & 2006 Nature Publishing Group All rights reserved 1365-7852/06 $30.00 www.nature.com/pcan REVIEW Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer Y Liu Nuclear Medicine Service, Department of Radiology, New Jersey Medical School, University of Medicine & Dentistry of New Jersey, Newark, NJ, USA Most malignancies have increased glycolysis for energy requirement of rapid cell proliferation, which is the basis for tumor imaging through glucose analog FDG (2-deoxy-2-fluoro-D-glucose) with positron emission tomography. One of significant characteristics of prostate cancer is slow glycolysis and low FDG avidity. Recent studies showed that prostate cancer is associated with changes of fatty acid metabolism. Several enzymes involved in the metabolism of fatty acids have been determined to be altered in prostate cancer relative to normal prostate, which is indicative of an enhanced b-oxidation pathway in prostate cancer. Increased fatty acid utilization in prostate cancer provides both ATP and acetyl-coenzyme A (CoA); subsequently, increased availability of acetyl-CoA makes acceleration of citrate oxidation possible, which is an important energy source as well. Dominant fatty acid metabolism rather than glycolysis has the potential to be the basis for imaging diagnosis and targeted treatment of prostate cancer. Prostate Cancer and Prostatic Diseases (2006) 9, 230–234. doi:10.1038/sj.pcan.4500879; published online 9 May 2006 Keywords: glycolysis; fatty acid metabolism; b-oxidation Introduction cells forms the theoretic basis for cancer detection through uptake of the glucose analog, fluorine-18-labeled Metabolic changes during malignant transformation 2-deoxy-2-fluoro-D-glucose (F18-FDG) with positron have been noted for many years. Warburg1 first reported emission tomography (PET). Today, FDG-PET has been that cancer cells preferentially rely on glycolysis as a widely used for diagnosis, staging, restaging and major bioenergetic source even in the presence of oxygen monitoring therapy of various kinds of malignant and produce high levels of lactate and pyruvate. diseases. Glycolysis is a metabolic pathway by which glucose is Glucose uptake across the plasma membrane is converted to pyruvate with the generation of 2 molecules considered the rate-limiting step for glucose consump- of ATP per molecule of glucose. Most non-dividing tion in cells.3 Transport of polar glucose across the normal tissue, such as muscle, fully oxidize private nonpolar plasma membrane relies on glucose transporter formed from glycolysis to carbon dioxide and water in protein, known as GLUTs. The previous study showed the mitochondrion with production of 38 molecules of that there are increased GLUT expression in the ATP per molecule of glucose. These normal tissues membrane of the malignant cells compared to normal generally do not convert glucose to lactic acid except cells, which may be a key step for subsequent tissue FDG when starved of oxygen. In contrast, tumors are accumulation.4,5 Among total 13 members of facilitative characterized by converting much of glucose into lactic GLUTs, cellular F18-FDG uptake is predominantly acid with sacrificing energy availability even in the related to expression of GLUT1.6,7 presence of oxygen. The rate at which tumors convert Prostate cancer remains a major concern of public glucose to lactic acid via glycolysis is generally correlated health. It is the most prevalent cancer in human beings with their rate of proliferation and degree of aggressive- and the second leading cause of male cancer death in the ness.2 US. FDG-PET has not been very helpful in staging or Increased glucose consumption is a basic characteristic detection of recurrence of prostate cancer because of low of malignant cells and is linked to energy production glycolysis. Clinical trial showed that FDG accumulation from glycolysis. Amplified glucose usage by malignant does not correlate with increasing grade or stage of the tumor and there is a significant overlap in FDG uptake between benign prostate hyperplasia and prostate Correspondence: Dr Y Liu, H-141, Nuclear Medicine, University cancer.8,9 Recent study revealed that GLUT1 mRNA Hospital, 150 Bergen Street, Newark, NJ 07101, USA. E-mail: [email protected] and protein were only very weakly expressed in human Received 26 January 2006; revised 29 March 2006; accepted 29 March prostate cancer tissue, which is considered to account for 10 2006; published online 9 May 2006 low FDG avidity of prostate cancer. In vitro study also Fatty acid metabolism and prostate cancer Y Liu suggested that glucose may not be required for andro- would produce increasing level of palmitate,23 which 231 gen-dependent prostate cancer cells because LNCaP cells further drives fatty acid oxidation. can grow at control rates even in the presence of only (3) b-Oxidation is the most prominent oxidation 0.05 g/l glucose.11 As rapid cell proliferation in malig- reaction for fatty acids and occurs both in the peroxisome nant tumors is associated with increased energy supply, and in the mitochondrion in higher eucaryotes. In if glucose consumption is not elevated in prostate cancer, contrast to mitochondrial b-oxidation, peroxisomal alterative metabolic approach, especially fatty acid b-oxidation does not contribute to energy production oxidation may exist dominantly to provide bioenergy directly, but is required for the initial oxidation of very for abnormal cells proliferation and growth. long chain fatty acids, branched chain fatty acids, bile acid intermediates and other fatty acid derivatives, which cannot be directly oxidized by the mitochondrion. There are two separate b-oxidation pathways in the Changes of fatty acid metabolism in peroxisome: the classical peroxisome proliferators-indu- prostate cancer cible pathway and non-inducible pathway composed of branched chain acyl-CoA oxidase (ACOX2) and/or Early observation suggested that in addition to the pristanoyl-CoA oxidase (ACOX3), D-bifunctional protein striking changes of glucose metabolism in human cancer, (DBP), and sterol carrier protein X.26,27 Recent study in there is often also an increase in free fatty acid turnover, vitro by Zha et al.28 showed that there is increased oxidation and clearance.12,13 The most recent study expression of mRNA, protein and accompanied enzy- showed that a lipid mobilizing factor produced by the matic activity of DBP in prostate cancer. Furthermore, pancreatic tumor cells appears to be responsible for the their data suggested that ACOX3 is expressed in increase in whole body fatty acid oxidation.14 Recent significant level, which might contribute to peroxisomal studies revealed that prostate cancer is associated with branched chain fatty acid b-oxidation in human prostate changes of fatty acid metabolism. Several proteins cancer. The study implied that increased peroxisomal involved in the metabolism of fatty acids have been branched chain fatty acid b-oxidation might provide determined to be altered in neoplastic prostate cells unique metabolic pathway for prostate transformation. relative to their normal counterparts. (4) There is some striking direct evidence of increased (1) Fatty acid metabolism represents a key process that fatty acid oxidation in prostate cancer recently. influences several diverse cellular pathways and char- a-Methylacyl-CoA racemase (AMACR) is a peroxisomal acteristics including cell signaling, energy processing and mitochondrial enzyme involved in the b-oxidation of and membrane fluidity.15,16 Fatty acid synthase (FAS) is branched fatty acid. Both in the peroxisome and the considered to be a possible metabolic oncogene in mitochondrion, AMACR is required to catalyze the prostate cancer.17 Fatty acid synthase is overexpressed interconversion of the R- and S-isomers, which is at both protein and mRNA levels in prostate cancer.18,19 necessary before oxidation can proceed. Multiple studies Its high expression has also been associated with revealed the consistent and specific overexpression of aggressive biologic behavior.18 Interestingly, the highest AMACR in prostate cancer versus normal prostate.29–32 levels of FAS expression are found in androgen-inde- Sequence variants of AMACR have been linked to pendent bone metastases.19 Although it is possible that prostate cancer risk. a-Methylacyl-CoA racemase enzy- synthesis of fatty acids is required for the biogenesis of matic activity is consistently elevated in prostate cancer cellular membranes in rapidly dividing tumor cells, the tissue specimen.32 All these are indicative of an enhanced simultaneous synthesis and breakdown of fatty acid is b-oxidative pathway in prostate cancer, which provides another explanation, which provides an energy source as ATP as an energy source. a futile cycle in prostate cancer. The inhibition of FAS activity induces cell death in FAS-overexpressing cancer cell lines and prolongs survival of host animals implanted with tumor xenografts.20–22 Fatty acid metabolism and citrate (2) Loss of stearoyl-CoA desaturase (SCD) expression oxidation in prostate cancer is a frequent event in prostate cancer.23 Stearoyl-CoA desaturase encodes a key rate-limiting enzyme involved It is known that increased citrate oxidation is a in the synthesis of monounsaturated fatty acids. There significant metabolic characteristic for the bioenergy was a significant reduction or complete lack of SCD requirement in prostate cancer. The normal human transcripts and protein expression
Load more

Recommended publications
  • Amphibolic Nature of Krebs Cycle
    Amphibolic nature of Krebs Cycle How what we are is what we eat • In aerobic organisms, the citric acid cycle is an amphibolic pathway, one that serves in both catabolic and anabolic processes. • Since the citric acid does both synthesis (anabolic) and breakdown (catabolic) activities, it is called an amphibolic pathway • The citric acid cycle is amphibolic (i.e it is both anabolic and catabolic in its function). • It is said to be an AMPHIBOLIC pathway, because it functions in both degradative or catabolic and biosynthetic or anabolic reactions (amphi = both) A central metabolic pathway or amphibolic pathway is a set of reactions which permit the interconversion of several metabolites, and represents the end of the catabolism and the beginning of anabolism • The KREBS CYCLE or citric acid cycle is a series of reactions that degrades acetyl CoA to yield carbon dioxide, and energy, which is used to produce NADH, H+ and FADH. • The KREBS CYCLE connects the catabolic pathways that begin with the digestion and degradation of foods in stages 1 and 2 with the oxidation of substrates in stage 3 that generates most of the energy for ATP synthesis. • The citric acid cycle is the final common pathway in the oxidation of fuel molecules. In stage 3 of metabolism, citric acid is a final common catabolic intermediate in the form of acetylCoA. • This is why the citric acid cycle is called a central metabolic pathway. Anaplerosis and Cataplerosis Anaplerosis is a series of enzymatic reactions in which metabolic intermediates enter the citric acid cycle from the cytosol. Cataplerosis is the opposite, a process where intermediates leave the citric acid cycle and enter the cytosol.
    [Show full text]
  • Fructose Metabolism from a Functional
    SSE #174 Sports Science Exchange (2017) Vol. 28, No. 174, 1-5 FRUCTOSE METABOLISM FROM A FUNCTIONAL PERSPECTIVE: IMPLICATIONS FOR ATHLETES Luke Tappy, MD | Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Service of Endocrinology, Diabetes and Metabolism | Lausanne University Hospital, and Cardio-metabolic Center, Broye Hospital | Estavayer-le-lac, Switzerland • Fructose was originally a seasonal natural nutrient, mainly consumed in summer and fall in fruits and vegetables. In the industrial era, it became a permanent constituent of our diet, essentially a constituent of added sugars (sucrose, high-fructose corn syrup). • Fructose cannot be directly metabolized by most cells in our body. It has to be processed first in the gut, liver and kidneys, where it is converted into glucose, lactate and fatty acids. • Too much dietary fructose along with excess energy intake and low physical activity can cause hepatic insulin resistance, hypertriglyceridemia and increased hepatic fat content. GAT11LOGO_GSSI_vert_fc_grn • In exercising athletes, net carbohydrate oxidation increases with glucose ingestion in a dose-dependent manner until a plateau is reached at about 1g/min. The addition of fructose to glucose drinks can further increase carbohydrate oxidation. • During exercise, substantial amounts of fructose can be converted into lactate in splanchnic organs if available and released in the systemic circulation to be oxidized in contracting muscles. This “reverse fructose-lactate Cori cycle” provides additional energy substrate to muscle during exercise. • Conversion of fructose into glucose and lactate in splanchnic organs is associated with enhanced splanchnic energy expenditure, while muscle energy efficiency is minimally altered. • During recovery after exercise, glucose and fructose mutually enhance their gut absorption and their storage as glycogen in the liver.
    [Show full text]
  • • Glycolysis • Gluconeogenesis • Glycogen Synthesis
    Carbohydrate Metabolism! Wichit Suthammarak – Department of Biochemistry, Faculty of Medicine Siriraj Hospital – Aug 1st and 4th, 2014! • Glycolysis • Gluconeogenesis • Glycogen synthesis • Glycogenolysis • Pentose phosphate pathway • Metabolism of other hexoses Carbohydrate Digestion! Digestive enzymes! Polysaccharides/complex carbohydrates Salivary glands Amylase Pancreas Oligosaccharides/dextrins Dextrinase Membrane-bound Microvilli Brush border Maltose Sucrose Lactose Maltase Sucrase Lactase ‘Disaccharidase’ 2 glucose 1 glucose 1 glucose 1 fructose 1 galactose Lactose Intolerance! Cause & Pathophysiology! Normal lactose digestion Lactose intolerance Lactose Lactose Lactose Glucose Small Intestine Lactase lactase X Galactose Bacteria 1 glucose Large Fermentation 1 galactose Intestine gases, organic acid, Normal stools osmotically Lactase deficiency! active molecules • Primary lactase deficiency: อาการ! genetic defect, การสราง lactase ลด ลงเมออายมากขน, พบมากทสด! ปวดทอง, ถายเหลว, คลนไสอาเจยนภาย • Secondary lactase deficiency: หลงจากรบประทานอาหารทม lactose acquired/transient เชน small bowel เปนปรมาณมาก เชนนม! injury, gastroenteritis, inflammatory bowel disease! Absorption of Hexoses! Site: duodenum! Intestinal lumen Enterocytes Membrane Transporter! Blood SGLT1: sodium-glucose transporter Na+" Na+" •! Presents at the apical membrane ! of enterocytes! SGLT1 Glucose" Glucose" •! Co-transports Na+ and glucose/! Galactose" Galactose" galactose! GLUT2 Fructose" Fructose" GLUT5 GLUT5 •! Transports fructose from the ! intestinal lumen into enterocytes!
    [Show full text]
  • Inhibition of Fructolytic Enzymes in Boar Spermatozoa by (S)-A-Chlorohydrin and L-Chloro-3-Hydroxypropanone
    Aust. J. BioI. Sci., 1986, 39, 395-406 Inhibition of Fructolytic Enzymes in Boar Spermatozoa by (S)-a-Chlorohydrin and l-Chloro-3-hydroxypropanone A. R. Jones, W. A. Bubb, S. R. Murdoch, and D. A. Stevenson Department of Biochemistry, The University of Sydney, New South Wales 2006. Abstract When boar spermatozoa were incubated with the (S)-isomer of the male antifertility agent a-chlorohydrin the activity of glyceraldehyde-3-phosphate dehydrogenase was inhibited. The (R)-isomer had no significant effect on the activity of this enzyme whereas (R,S)-3-chlorolactaldehyde caused an inhibition of its activity and also in that of lactate dehydrogenase. The in vitro production of (S)-3-chlorolactaldehyde, the active metabolite of (S)-a-chlorohydrin, was attempted by incubating boar spermatozoa with l-chloro-3- hydroxypropanone. Preliminary results lead us to propose that this compound is converted into (S)-3- chlorolactaldehyde as well as to another metabolite which is an inhibitor of other enzymes within the fructolytic pathway. Introduction Of the many non-steroidal chemicals which are known to elicit an antifertility response in the male (Jackson 1966), only one compound has most of the attributes of an ideal male contraceptive. This compound, (S)-a-chlorohydrin [(S)-3-chloro­ propan-l,2-diol, I (Fig. 1)], affects the metabolic activity of mature spermatozoa by inhibiting the activity of the glycolytic or fructolytic enzyme glyceraldehyde- 3-phosphate dehydrogenase (Ee 1.2.1.12) thereby causing a decrease in the fructolytic flux. This limits the capability of the spermatozoa to synthesize ATP so that when CHpH I c=o I CH2C1 III Fig.
    [Show full text]
  • Extracellular Adenosine Triphosphate and Adenosine in Cancer
    Oncogene (2010) 29, 5346–5358 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 www.nature.com/onc REVIEW Extracellular adenosine triphosphate and adenosine in cancer J Stagg and MJ Smyth Cancer Immunology Program, Sir Donald and Lady Trescowthick Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia Adenosine triphosphate (ATP) is actively released in the mulated the hypothesis of purinergic neurotransmission extracellular environment in response to tissue damage (Burnstock, 1972). Burnstock’s hypothesis that ATP and cellular stress. Through the activation of P2X and could be released by cells to perform intercellular P2Y receptors, extracellular ATP enhances tissue repair, signaling was initially met with skepticism, as it seemed promotes the recruitment of immune phagocytes and unlikely that a molecule that acts as an intracellular dendritic cells, and acts as a co-activator of NLR family, source of energy would also function as an extracellular pyrin domain-containing 3 (NLRP3) inflammasomes. messenger. Nevertheless, Burnstock pursued his work The conversion of extracellular ATP to adenosine, in and, together with Che Su and John Bevan, reported contrast, essentially through the enzymatic activity of the that ATP was also released from sympathetic nerves ecto-nucleotidases CD39 and CD73, acts as a negative- during stimulation (Su et al., 1971). Three decades later, feedback mechanism to prevent excessive immune responses. following the cloning and characterization of ATP and Here we review the effects of extracellular ATP and adenosine adenosine cell surface receptors, purinergic signaling is a on tumorigenesis. First, we summarize the functions of well-established concept and constitutes an expanding extracellular ATP and adenosine in the context of tumor field of research in health and disease, including cancer immunity.
    [Show full text]
  • Fatty Acid Biosynthesis
    BI/CH 422/622 ANABOLISM OUTLINE: Photosynthesis Carbon Assimilation – Calvin Cycle Carbohydrate Biosynthesis in Animals Gluconeogenesis Glycogen Synthesis Pentose-Phosphate Pathway Regulation of Carbohydrate Metabolism Anaplerotic reactions Biosynthesis of Fatty Acids and Lipids Fatty Acids contrasts Diversification of fatty acids location & transport Eicosanoids Synthesis Prostaglandins and Thromboxane acetyl-CoA carboxylase Triacylglycerides fatty acid synthase ACP priming Membrane lipids 4 steps Glycerophospholipids Control of fatty acid metabolism Sphingolipids Isoprene lipids: Cholesterol ANABOLISM II: Biosynthesis of Fatty Acids & Lipids 1 ANABOLISM II: Biosynthesis of Fatty Acids & Lipids 1. Biosynthesis of fatty acids 2. Regulation of fatty acid degradation and synthesis 3. Assembly of fatty acids into triacylglycerol and phospholipids 4. Metabolism of isoprenes a. Ketone bodies and Isoprene biosynthesis b. Isoprene polymerization i. Cholesterol ii. Steroids & other molecules iii. Regulation iv. Role of cholesterol in human disease ANABOLISM II: Biosynthesis of Fatty Acids & Lipids Lipid Fat Biosynthesis Catabolism Fatty Acid Fatty Acid Degradation Synthesis Ketone body Isoprene Utilization Biosynthesis 2 Catabolism Fatty Acid Biosynthesis Anabolism • Contrast with Sugars – Lipids have have hydro-carbons not carbo-hydrates – more reduced=more energy – Long-term storage vs short-term storage – Lipids are essential for structure in ALL organisms: membrane phospholipids • Catabolism of fatty acids –produces acetyl-CoA –produces reducing
    [Show full text]
  • Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
    life Review Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses Inseok Choi , Hyewon Son and Jea-Hyun Baek * School of Life Science, Handong Global University, Pohang, Gyeongbuk 37554, Korea; [email protected] (I.C.); [email protected] (H.S.) * Correspondence: [email protected]; Tel.: +82-54-260-1347 Abstract: The tricarboxylic acid cycle (TCA) is a series of chemical reactions used in aerobic organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from carbohydrates, fatty acids and proteins. In the eukaryotic system, the TCA cycle occurs completely in mitochondria, while the intermediates of the TCA cycle are retained inside mitochondria due to their polarity and hydrophilicity. Under cell stress conditions, mitochondria can become disrupted and release their contents, which act as danger signals in the cytosol. Of note, the TCA cycle intermediates may also leak from dysfunctioning mitochondria and regulate cellular processes. Increasing evidence shows that the metabolites of the TCA cycle are substantially involved in the regulation of immune responses. In this review, we aimed to provide a comprehensive systematic overview of the molecular mechanisms of each TCA cycle intermediate that may play key roles in regulating cellular immunity in cell stress and discuss its implication for immune activation and suppression. Keywords: Krebs cycle; tricarboxylic acid cycle; cellular immunity; immunometabolism 1. Introduction The tricarboxylic acid cycle (TCA, also known as the Krebs cycle or the citric acid Citation: Choi, I.; Son, H.; Baek, J.-H. Tricarboxylic Acid (TCA) Cycle cycle) is a series of chemical reactions used in aerobic organisms (pro- and eukaryotes) to Intermediates: Regulators of Immune generate energy via the oxidation of acetyl-coenzyme A (CoA) derived from carbohydrates, Responses.
    [Show full text]
  • Lipid Metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
    cancers Review Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives 1, 1, 1 2 1 Laurence Pellerin y, Lorry Carrié y , Carine Dufau , Laurence Nieto , Bruno Ségui , 1,3 1, , 1, , Thierry Levade , Joëlle Riond * z and Nathalie Andrieu-Abadie * z 1 Centre de Recherches en Cancérologie de Toulouse, Equipe Labellisée Fondation ARC, Université Fédérale de Toulouse Midi-Pyrénées, Université Toulouse III Paul-Sabatier, Inserm 1037, 2 avenue Hubert Curien, tgrCS 53717, 31037 Toulouse CEDEX 1, France; [email protected] (L.P.); [email protected] (L.C.); [email protected] (C.D.); [email protected] (B.S.); [email protected] (T.L.) 2 Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Toulouse III Paul-Sabatier, UMR 5089, 205 Route de Narbonne, 31400 Toulouse, France; [email protected] 3 Laboratoire de Biochimie Métabolique, CHU Toulouse, 31059 Toulouse, France * Correspondence: [email protected] (J.R.); [email protected] (N.A.-A.); Tel.: +33-582-7416-20 (J.R.) These authors contributed equally to this work. y These authors jointly supervised this work. z Received: 15 September 2020; Accepted: 23 October 2020; Published: 27 October 2020 Simple Summary: Melanoma is a devastating skin cancer characterized by an impressive metabolic plasticity. Melanoma cells are able to adapt to the tumor microenvironment by using a variety of fuels that contribute to tumor growth and progression. In this review, the authors summarize the contribution of the lipid metabolic network in melanoma plasticity and aggressiveness, with a particular attention to specific lipid classes such as glycerophospholipids, sphingolipids, sterols and eicosanoids.
    [Show full text]
  • Fatty Acid Synthesis ANSC/NUTR 618 Lipids & Lipid Metabolism Fatty Acid Synthesis I
    Handout 5 Fatty Acid Synthesis ANSC/NUTR 618 Lipids & Lipid Metabolism Fatty Acid Synthesis I. Overall concepts A. Definitions 1. De novo synthesis = synthesis from non-fatty acid precursors a. Carbohydrate precursors (glucose and lactate) 1) De novo fatty acid synthesis uses glucose absorbed from the diet rather than glucose synthesized by the liver. 2) De novo fatty acid synthesis uses lactate derived primarily from glucose metabolism in muscle and red blood cells. b. Amino acid precursors (e.g., alanine, branched-chain amino acids) 1) De novo fatty acid synthesis from amino acids is especially important during times of excess protein intake. 2) Use of amino acids for fatty acid synthesis may result in nitrogen overload (e.g., the Atkins diet). c. Short-chain organic acids (e.g., acetate, butyrate, and propionate) 1) The rumen of ruminants is a major site of short-chain fatty acid synthesis. 2) Only small amounts of acetate circulate in non-ruminants. 2. Lipogenesis = fatty acid or triacylglycerol synthesis a. From preformed fatty acids (from diet or de novo fatty acid synthesis) b. Requires source of carbon (from glucose or lactate) for glycerol backbone 3T3-L1 Preadipocytes at confluence. No lipid 3T3-L1 Adipocytes after 6 days of filling has yet occurred. differentiation. Dark spots are lipid droplets. 1 Handout 5 Fatty Acid Synthesis B. Tissue sites of de novo fatty acid biosynthesis 1. Liver. In birds, fish, humans, and rodents (approx. 50% of fatty acid biosynthesis). 2. Adipose tissue. All livestock species synthesize fatty acids in adipose tissue; rodents synthesize about 50% of their fatty acids in adipose tissue.
    [Show full text]
  • Beta (Β)-Oxidation of Fatty Acid and Its Associated Disorders
    Vol. 5 (1), pp. 158-172, December, 2018 ©Global Science Research Journals International Journal of Clinical Biochemistry Author(s) retain the copyright of this article. http://www.globalscienceresearchjournals.org/ Review Article Beta (β)-Oxidation of Fatty Acid and its associated Disorders Satyam Prakash Assistant Professor, Dept. of Biochemistry, Janaki Medical College Teaching Hospital, Janakpur, Nepal Mobile: +977-9841603704, E-mail: [email protected] Accepted 18 December, 2018 The lipids of metabolic significance in the mammalian organisms include triacylglycerols, phospholipids and steroids, together with products of their metabolism such as long-chain fatty acids, glycerol and ketone bodies. The fatty acids which are present in the triacylglycerols in the reduced form are the most abundant source of energy and provide energy twice as much as carbohydrates and proteins. Fatty acids represent an important source of energy in periods of catabolic stress related to increased muscular activity, fasting or febrile illness, where as much as 80% of the energy for the heart, skeletal muscles and liver could be derived from them. The prime pathway for the degradation of fatty acids is mitochondrial fatty acid β-oxidation (FAO). The relationship of fat oxidation with the utilization of carbohydrate as a source of energy is complex and depends upon tissue, nutritional state, exercise, development and a variety of other influences such as infection and other pathological states. Inherited defects for most of the FAO enzymes have been identified and characterized in early infancy as acute life-threatening episodes of hypoketotic, hypoglycemic coma induced by fasting or febrile illness. Therefore, this review briefly highlights mitochondrial β-oxidation of fatty acids and associated disorders with clinical manifestations.
    [Show full text]
  • Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
    Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation de Andrade Mello, Paola, Robson Coutinho-Silva, and Luiz Eduardo Baggio Savio. 2017. “Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives.” Frontiers in Immunology 8 (1): 1526. doi:10.3389/fimmu.2017.01526. http://dx.doi.org/10.3389/ fimmu.2017.01526. Published Version doi:10.3389/fimmu.2017.01526 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34493041 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA REVIEW published: 14 November 2017 doi: 10.3389/fimmu.2017.01526 Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives Paola de Andrade Mello1, Robson Coutinho-Silva 2* and Luiz Eduardo Baggio Savio2* 1 Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States, 2Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil Cancer is still one of the world’s most pressing health-care challenges, leading to a high number of deaths worldwide. Immunotherapy is a new developing therapy that Edited by: boosts patient’s immune system to fight cancer by modifying tumor–immune cells Salem Chouaib, interaction in the tumor microenvironment (TME).
    [Show full text]
  • Cell Signaling and Regulation of Metabolism Objectives
    Cell Signaling and Regulation of Metabolism Objectives By the end of this lecture, students are expected to: • Differentiate different steps in signaling pathways • Describe the second messenger systems • Recognize the function of signaling pathways for • Signal transmission • Amplification • Discuss the role of signaling pathways in regulation and integration of metabolism No cell lives in isolation • Cells communicate with each other • Cells send and receive information (signals) • Information is relayed within cell to produce a response Signaling Process • Recognition of signal – Receptors • Transduction – Change of external signal into intracellular message with amplification and formation of second messenger • Effect – Modification of cell metabolism and function General Signaling Pathway Signaling Cascades Recognition • Performed by receptors • Ligand will produce response only in cells that have receptors for this particular ligand • Each cell has a specific set of receptors Different Responses to the Same Signaling Molecule. (A) Different Cells Different Responses to the Same Signaling Molecule. (B) One Cell but, Different Pathways Hypoglycemia Glucagon secretion Hepatocyte: Glucagon/receptor binding Second messenger: cAMP Response: Enzyme phosphorylation P P Glycogen synthase Glycogen phosphorylase (Inactive form) (Active form) Inhibition of glycogenesis Stimulation of glycogenolysis GTP-Dependant Regulatory Proteins (G-Proteins) G-Proteins: Trimeric membrane proteins (αβγ) G-stimulatory (Gs) and G-inhibitory (Gi) binds to GTP/GDP
    [Show full text]